These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20228142)

  • 1. Prevention and medical management of Clostridium difficile infection.
    Shannon-Lowe J; Matheson NJ; Cooke FJ; Aliyu SH
    BMJ; 2010 Mar; 340():c1296. PubMed ID: 20228142
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host and pathogen factors for Clostridium difficile infection and colonization.
    Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
    N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.
    Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY
    J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.
    Wilkinson K; Gravel D; Taylor G; McGeer A; Simor A; Suh K; Moore D; Kelly S; Boyd D; Mulvey M; Mounchili A; Miller M;
    Am J Infect Control; 2011 Apr; 39(3):177-82. PubMed ID: 21458680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for prevention of Clostridium difficile infection.
    Dubberke E
    J Hosp Med; 2012 Mar; 7 Suppl 3():S14-7. PubMed ID: 22407995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curtailing the spread of disease.
    Dunne ME; Greenough W
    Adv Nurse Pract; 2006 Jun; 14(6):63-6. PubMed ID: 16972462
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium difficile. A super serious bug.
    Mayo Clin Health Lett; 2012 Apr; 30(4):6. PubMed ID: 22649818
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium difficile infection and colonization.
    Lapane KL; Motzkus-Feagans C; Pakyz A
    N Engl J Med; 2012 Jan; 366(3):276; author reply 276-7. PubMed ID: 22256813
    [No Abstract]   [Full Text] [Related]  

  • 12. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fidaxomicin for Clostridium difficile infection.
    Linsky A; Gupta K; Hermos JA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostridium difficile infection in hospitals: risk factors and responses.
    Louie TJ; Meddings J
    CMAJ; 2004 Jul; 171(1):45-6. PubMed ID: 15238495
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical inquiry: what risk factors contribute to C difficile diarrhea?
    Fashner J; Garcia M; Ribble L; Crowell K
    J Fam Pract; 2011 Sep; 60(9):545-7. PubMed ID: 21901182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile: an intestinal infection on the rise.
    Harv Mens Health Watch; 2010 Jun; 14(11):5-8. PubMed ID: 20597186
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes?
    Imhoff A; Karpa K
    Nutr Clin Pract; 2009; 24(1):15-32. PubMed ID: 19244145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Re-emergent etiologies: Clostridium difficile].
    Mare A; Man A; Toma F; Szekely E; Lörinczi L
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):181-8. PubMed ID: 19326731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.
    Nachnani JS; Bulchandani D; Allen MJ
    Indian J Gastroenterol; 2008; 27(4):171-2. PubMed ID: 18974472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.